[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apimeds Pharmaceuticals US Inc (APUS)

Apimeds Pharmaceuticals US Inc (APUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,866
  • Shares Outstanding, K 15,091
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,000 K
  • EBIT $ -24 M
  • EBITDA $ -24 M
  • 60-Month Beta -0.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.07
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.74
  • Most Recent Earnings $-2.26 on 05/26/26
  • Next Earnings Date 08/18/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6794 +5.98%
on 07/10/26
1.5500 -53.55%
on 06/22/26
-0.5700 (-44.19%)
since 06/10/26
3-Month
0.6794 +5.98%
on 07/10/26
5.9700 -87.94%
on 05/05/26
-1.1600 (-61.70%)
since 04/02/26
52-Week
0.6794 +5.98%
on 07/10/26
5.9700 -87.94%
on 05/05/26
-1.0900 (-60.22%)
since 07/10/25

Most Recent Stories

More News
MindWave Innovations (NYSE American: APUS) Building an Ecosystem Designed to Unlock the Full Potential of Digital Asset Treasury Management

Holding digital assets was once largely viewed as a passive strategy centered on long-term appreciation, inflation protection and portfolio diversification. Today, however, institutional investors are...

APUS : 0.7200 (-2.04%)
MindWave Innovations (NYSE American: APUS) Builds Institutional Bridge for Bitcoin Treasury Adoption

As bitcoin moves deeper into corporate finance, the central question for many companies is no longer whether digital assets belong on the balance sheet but rather how they can be held, reported and deployed...

^XMYBTC : 0.000003 (+200.00%)
APUS : 0.7200 (-2.04%)
^BTCUSDT : 64,203.76 (+0.57%)
^BTCUSD : 64,168.26 (+0.60%)
The Infrastructure Gap Behind Corporate Bitcoin Adoption

In corporate finance, treasury management has traditionally centered on capital preservation, liquidity, internal controls, and predictable yield. That framework is being tested as a growing number of...

^XMYBTC : 0.000003 (+200.00%)
APUS : 0.7200 (-2.04%)
^BTCUSDT : 64,203.76 (+0.57%)
^BTCUSD : 64,168.26 (+0.60%)
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

Trading Expected to Resume on NYSE American on Tuesday, May 5

APUS : 0.7200 (-2.04%)
Apimeds Pharmaceuticals Investor News: Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) resulting...

APUS : 0.7200 (-2.04%)
Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Apimeds Pharmaceuticals US, Inc. (NYSE American:...

APUS : 0.7200 (-2.04%)
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.

Rejects Allegations of MindWave Innovations, Inc. SEOUL, South Korea, March 25, 2026 (GLOBE NEWSWIRE) --  Inscobee Inc. (“Inscobee”) and Apimeds, Inc., (“Apimeds Korea”) today announced...

APUS : 0.7200 (-2.04%)
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.

Rejects Allegations of MindWave Innovations, Inc. SEOUL, South Korea, March 25, 2026 (GLOBE NEWSWIRE) --  Inscobee Inc. (“Inscobee”) and Apimeds, Inc., (“Apimeds Korea”) today announced...

APUS : 0.7200 (-2.04%)
Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

MindWave Innovations Inc., a Delaware corporation and wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (“APUS” or the “Company”) (NYSE American: APUS), today announced that on March...

APUS : 0.7200 (-2.04%)
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

Apimeds Pharmaceuticals US, Inc. and Lōkahi Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) Division of Anesthesiology, Addiction Medicine and Pain Medicine (DAAP)...

APUS : 0.7200 (-2.04%)

Business Summary

Apimeds Pharmaceuticals US Inc. operates as a clinical stage biopharmaceutical company. It researches, develops, manufactures, commercializes and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple...

See More

Key Turning Points

3rd Resistance Point 0.8241
2nd Resistance Point 0.7871
1st Resistance Point 0.7535
Last Price 0.7200
1st Support Level 0.6829
2nd Support Level 0.6459
3rd Support Level 0.6123

See More

52-Week High 5.9700
Fibonacci 61.8% 3.9490
Fibonacci 50% 3.3247
Fibonacci 38.2% 2.7004
Last Price 0.7200
52-Week Low 0.6794

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.